EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Salivary Il-6, Ifn-Γ and Rage Levels Before and After Topical Betamethasone Nanogel Therapy in Oral Lichen Planus Patients

Sharan Mann, Sreedevi Dharman

International Journal of Drug Delivery Technology · 11.06.2026 · 16 (52s)

DOI: 10.25258/ijddt.16.52s.68 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.06.2026. Verfasst von Sharan Mann und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral lichen planus (OLP) is a chronic immune-mediated inflammatory disorder associated with mucosal pain and functional discomfort. Salivary biomarkers such as IL-6, IFN-γ, and RAGE may reflect disease activity and treatment response. Betamethasone nanogel may improve topical corticosteroid delivery because of its mucoadhesive and sustained-release properties.

Aim

To evaluate salivary IL-6, IFN-γ, and RAGE levels before and after topical betamethasone nanogel therapy in patients with OLP and to assess associated clinical improvement using the Oral Disease Severity Score (ODSS). Materials and Methods: This prospective pre–post interventional study included 10 patients with symptomatic OLP. All patients received topical betamethasone nanogel twice daily for 14 days. Clinical severity was assessed using ODSS at baseline and post-treatment. Unstimulated whole saliva samples were collected at both time points, and salivary IL-6, IFN-γ, and RAGE levels were estimated by ELISA.

Results

All patients completed the study and no adverse effects were observed. Mean ODSS decreased significantly from 6.40 ± 4.45 to 5.00 ± 2.98 (p = 0.0313). Salivary IL-6 decreased from 35.30 ± 0.43 pg/mL to 27.39 ± 0.74 pg/mL, IFN-γ from 56.89 ± 3.30 pg/mL to 35.27 ± 2.67 pg/mL, and RAGE from 357.56 ± 20.40 pg/mL to 274.26 ± 12.26 pg/mL. All biomarker reductions were highly significant (p < 0.001).

Conclusion

Topical betamethasone nanogel resulted in significant clinical and biochemical improvement in OLP. The reduction in ODSS and salivary IL-6, IFN-γ, and RAGE levels suggests that it may be an effective localized antiinflammatory therapy, while salivary biomarkers may serve as useful adjuncts for monitoring treatment response.

Zitieren

APA

Mann, S., & Dharman, S. (2026). Evaluation of Salivary Il-6, Ifn-Γ and Rage Levels Before and After Topical Betamethasone Nanogel Therapy in Oral Lichen Planus Patients. International Journal of Drug Delivery Technology, 16(52s). https://doi.org/10.25258/ijddt.16.52s.68

Vancouver

Mann S, Dharman S. Evaluation of Salivary Il-6, Ifn-Γ and Rage Levels Before and After Topical Betamethasone Nanogel Therapy in Oral Lichen Planus Patients. International Journal of Drug Delivery Technology. 2026;16(52s). doi:10.25258/ijddt.16.52s.68

BibTeX
@article{Mann2026,
  author = {Mann, Sharan and Dharman, Sreedevi},
  title = {Evaluation of Salivary Il-6, Ifn-Γ and Rage Levels Before and After Topical Betamethasone Nanogel Therapy in Oral Lichen Planus Patients},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {52s},
  doi = {10.25258/ijddt.16.52s.68}
}
Kostenlos starten →